Status:
COMPLETED
Trial Applying Policy to Eliminate or Reduce Inappropriate Narcotics in the General-population
Lead Sponsor:
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Inappropriate Dose of Drug Administered
Pain, Chronic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To assess the effectiveness of a government-led population-based opioid intervention on discontinuation of opioid medication in community-dwelling adults with chronic non-cancer pain.
Eligibility Criteria
Inclusion
- Adults registered to receive pharmaceutical benefits in Manitoba, who are aged 18 years and over and who have received ≥90 days supply of opioids in the 6 months prior to the trial will be included. This will ensure chronic use and episodic use of opioids will be included.
Exclusion
- People receiving palliative care, people with cancer, and people who receive opioids in hospital. People with dementia (identified by having received a prescription for memantine or a cholinersterase inhibitor in the previous 12 months) will be excluded.
Key Trial Info
Start Date :
July 17 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
4255 Patients enrolled
Trial Details
Trial ID
NCT03400384
Start Date
July 17 2018
End Date
December 31 2019
Last Update
September 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut universitaire de gériatrie de Montréal
Montreal, Quebec, Canada, H3W1W5